Novel Lentiviral Models of HIV Neuropathogenesis (R21)

The summary for the Novel Lentiviral Models of HIV Neuropathogenesis (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Novel Lentiviral Models of HIV Neuropathogenesis (R21): -Purpose. The National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Drug Abuse (NIDA), the National Institute of Mental Health (NIMH), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) invite research grant applications aimed at developing and or refinement of animal or ex vivo cell culture model systems for study of the neurologic complications of AIDS, with or without a history of drug or alcohol use. Recent advances in the development of the SIV model system highlight the power of animal model systems for study of the mechanisms underlying the pathology associated with lentiviral infection in the nervous system. These models will be key for developing therapeutic approaches for the treatment of patients suffering from NeuroAIDS and for understanding the basic biology of infection with HIV/AIDS. -Mechanism of Support. This funding opportunity will use the NIH Research Project (R21) award mechanism, and runs in parallel with a FOA of identical scientific scope, PAS-08-178, that encourages applications under the NIH Research Project Grant (R01) award mechanism. For research projects with limited scope to develop animal or ex vivo models, applicants may submit their application in response to the NIH Small Research Grant Program (R03): http://grants.nih.gov/grants/guide/pa-files/PA-06-180.html
Federal Grant Title: Novel Lentiviral Models of HIV Neuropathogenesis (R21)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAS-08-179
Type of Funding: Grant
CFDA Numbers: 93.242
CFDA Descriptions: Mental Health Research Grants
Current Application Deadline: May 07, 2011
Original Application Deadline: May 07, 2011
Posted Date: Jun 18, 2008
Creation Date: Dec 05, 2008
Archive Date: Jun 07, 2011
Total Program Funding:
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...
Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH...
Interaction between ARVs and Hormones in HIV and Coinfections (R01 Clinical Trial Optional...
Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowe...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...
Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...
Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
More Grants from the National Institutes of Health
Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...
Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com